Healthcare Industry News: Ampion
News Release - September 24, 2015
Bovie Medical Corporation Signs GPO Agreement with Amerinet for J-PlasmaCLEARWATER, Fla.--(Healthcare Sales & Marketing Network)--Bovie Medical Corporation (“Bovie” or the “Company”) (BVX) a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, announced today that it has signed its first group purchasing organization (GPO) agreement with Amerinet for the use of J-Plasma by its members.
The 3-year agreement with Amerinet, one of the nation’s largest healthcare GPOs, is in effect now through September 2018. Amerinet has more than 85,000 members, including 33,000 clinics, 3,500 acute care hospitals, and 3,300 ambulatory surgery centers. Through this agreement, Amerinet members will have access to J-Plasma®, Bovie’s transformational surgical product, which enables surgeons to operate with greater precision and minimal thermal spread.
“This agreement represents an important step in advancing the adoption of J-Plasma, and we are delighted to partner with Amerinet, which has an excellent reputation for providing its members with high quality healthcare products at reasonable costs,” said Robert L. Gershon, Bovie’s Chief Executive Officer.
As a leading national healthcare solutions organization, Amerinet collaborates with acute and non-acute care providers to create and deliver unique supply chain solutions through performance improvement resources, guidance and ongoing support. With better product standardization and utilization, new financial tools beyond contracting and alliances that help lower costs, raise revenue and chAmpion quality, Amerinet enriches healthcare delivery for its members and the communities they serve. To learn more about how Amerinet can help you successfully navigate the future of healthcare, visit www.amerinet-gpo.com.
About Bovie Medical Corporation
Bovie Medical Corporation is a leading maker of medical devices and supplies as well as the developer of J-Plasma®, a patented new plasma-based surgical product for cutting and coagulation. J-Plasma® utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery. Bovie Medical Corporation is also a leader in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the Company’s own well-respected brands (Bovie®, Aaron®, IDS™ and ICON™) to distributors worldwide. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company’s current and new products, please refer to the Investor Relations section of Bovie Medical Corporation’s website www.boviemed.com
Source: Bovie Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.